Related Experiment Video
Updated: Jun 11, 2026

10:09
A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography HPLC
Published on: March 15, 2017
27.1K
Development and Application of KASP Markers for Candidate Glucosinolate Biosynthesis Genes in Broccoli
Sifan Du1,2, Yusen Shen2, Mengfei Song2
1College of Life Sciences, China Jiliang University, Hangzhou 310018, China.
International Journal of Molecular Sciences
|March 28, 2026
Summary
Researchers developed new molecular markers to improve broccoli's glucosinolate (GSL) content. A specific marker, S101 in the AOP2 gene, shows stable prediction for enhancing GSL composition in broccoli breeding.
Area of Science:
- Plant genetics
- Agricultural science
- Biochemistry
Background:
- Broccoli (Brassica oleracea) contains glucosinolates (GSLs), vital for plant defense and human health.
- Optimizing aliphatic GSL composition is a key breeding goal, but effective molecular markers are scarce.
Purpose of the Study:
- To develop and validate candidate gene-based kompetitive allele-specific PCR (KASP) markers for marker-assisted selection (MAS) of GSLs in broccoli.
- To identify robust markers for major aliphatic GSLs, specifically targeting AOP2 and GSL-OH.
Main Methods:
- Developed KASP markers from 19 GSL biosynthesis genes, focusing on AOP2 and GSL-OH.
- Evaluated marker-trait associations in natural and F2 broccoli populations.
- Utilized ROC analysis and GLM/MLM frameworks for validation.
Main Results:
- Marker S101 (AOP2) demonstrated consistent genotype-dependent effects on GNA and PRO content across populations.
- S101 showed strong classification performance for high- and low-GSL genotypes.
- Other markers (S074, S035) exhibited population-dependent associations.
Conclusions:
- Candidate gene-based KASP markers, particularly S101, hold significant potential for marker-assisted selection to enhance broccoli's aliphatic GSL profile.
- This approach can accelerate breeding programs for improved GSL content in broccoli.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

